Strong evidence for up-regulation of cyclooxygenase-1 in head and neck cancer

European Journal of Clinical Investigation

Volumn 38, Issue 1, 2008, Pages 61-66

  Erovic, B M ^a   Woegerbauer, M ^a   Pammer, J ^a   Selzer, E ^a   Grasl, M Ch ^a   Thurnher, D ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

COX 1; Head and neck cancer; Overexpression

Indexed keywords

CYCLOOXYGENASE 1; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER TISSUE; CONTROLLED STUDY; CYTOPLASM; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OROPHARYNX TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR BIOPSY; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CYCLOOXYGENASE 1; EPITHELIAL CELLS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OROPHARYNX; UP-REGULATION;

EID: 37349123160     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2007.01896.x     Document Type: Article

References (41)

1. Turini ME, DuBois RN. Cyclooxygenase-2: a therapeutic target. Annu Rev Med 2002 53:35 57.
2. Prescott SM, Fitzpatrick FA. Cyclooxygenase and Carcinogenesis. Biochimica et Biophysica Acta 2000 1470:M69 M78.
3. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999 18:7908 16.
4. Smith WL, Langenbach R. Why there are two cyclooxygenase isozymes. J Clin Invest 2001 107:1491 5.
5. Langenbach R, Loftin C, Lee C, Tiano H. Cyclooxygenase knockout mice: models for elucidating isoform-specific functions. Biochem Pharmacol 1999 58:1237 46.
6. Shamma A, Yamamoto H, Doki Y, Okami J, Kondo M, Fujiwara Y et al. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus. Clin Cancer Res 2000 61:229 38.
7. Ranelletti FO, Almadori G, Rocca B, Farrendina G, Ciabattoni G, Habib A et al. Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma. Int J Cancer 2001 95:343 9.
8. Wolff H, Saukkonen K, Anttila S, Karjalainen A, Vainio H, Ristimaki A. Expression of cyclooxygenase-2 in human lung carcinoma. Cancer Res 1998 58:4997 5001.
9. Erovic BM, Pelzmann M, Turhani D, Niederberger V, Neuchrist C, Grasl MC et al. Differential expression pattern of Cox-1 and Cox-2 in head and neck squamous cell carcinoma. Acta Otorlaryngol 2003 8:950 3.
10. Hahm KB, Lim HY, Sohn S, Kwon HJ, Lee KM, Lee JS et al. In vitro evidence of the role of COX-2 in attenuating gastric inflammation and promoting gastric carcinogenesis. J Environ Pathol Toxicol Oncol 2002 21:165 76.
11. Trifan OC, Hla T. Cyclooxygenase-2 modulates cellular growth and promotes tumorigenesis. J Cell Mol Med 2003 7:207 22.
12. Gupta RA, Tejada LV, Tong BJ, Das SK, Morrow JD, Dey SK et al. Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res 2003 63:906 11.
13. Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbourn HN. Cyclooxygenase-1 is up-regulated in cervical carcinomas. Cancer Res 2002 62:424 32.
14. Kim MH, Seo SS, Song YS, Kang DH, Park IA, Kang SB et al. Expression of cyclooxygenase-1 and -2 associated with expression of VEGF in primary cervical cancer and at metastatic lymph nodes. Gynecol Oncol 2003 90:83 90.
15. Kirschenbaum A, Klausner AP, Lee R, Unger P, Yao S, Liu XH et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human prostate. Urology 2000 56:671 6.
16. Hwang D, Scollard D, Byrne J, Levine E. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J Natl Cancer Inst 1998 90:455 60.
17. Dore M, Cote LC, Mitchell A, Sirois J. Expression of prostaglandin G/H synthase type 1, but not type 2, in human ovarian adenocarcinomas. J Histochem Cytochem 1998 46:77 84.
18. Daikoku T, Tranguch S, Chakrabarty A, Wang D, Khabele D, Orsulic S et al. Extracellular signal-regulated kinase is a target of cyclooxygenase-1- peroxisome proliferator-activated receptor-delta signalling in epithelial ovarian cancer. Cancer Res 2007 67:5285 92.
19. Daikoku T, Tranguch S, Trofimova IN, Dinulescu DM, Jacks T, Nikitin AY et al. Cyclooxygenase-1 is overexpressed in multiple genetically engineered mouse models of epithelial ovarian cancer. Cancer Res 2006 66:2527 31.
20. Shibata M, Kodani I, Osaki M, Araki K, Adachi H, Ryoke K et al. Cyclo-oxygenase-1 and -2 expression in human oral mucosa, dysplasias and squamous cell carcinomas and their pathological significance. Oral Oncol 2005 41:304 12.
21. Kase S, Osaki M, Honjo S, Hashimoto K, Adachi H, Tsujitani S et al. Expression of cyclooxygenase-1 and cyclooxygenase-2 in human esophageal mucosa, dysplasia and carcinoma. Pathobiology 2004 71:84 92.
22. Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol 1998 38:97 120.
23. Vane JR, Mitchell JA, Appleton I, Tomlinson A, Bishop-Bailey D, Croxtall J et al. Inducible isoforms of cyclooxygenase and nitric-oxide synthase in inflammation. Proc Natl Acad Sci U S A 1994 91:2046 50.
24. Ferrandina G, Ranelletti FO, Legge F, Lauriola L, Salutari V, Gessi M et al. Celecoxib modulates the expression of cyclooxygenase-2, ki67, apoptosis-related marker, and microvessel density in human cervical cancer: a pilot study. Clin Cancer Res 2003 9:4324 31.
25. Lin DT, Subbaramaiah K, Shah JP, Dannenberg AJ, Boyle JO. Cyclooxygenase-2: a novel molecular target for the prevention and treatment of head and neck cancer. Head Neck 2002 24:792 9.
26. Altorki NK, Keresztes RS, Port JL, Libby DM, Korst RJ, Flieder DB et al. Celecoxib, a selective cyclo-oxygenase-2 inhibitor, enhances the response to preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer. J Clin Oncol 2003 21:2645 50.
27. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB et al. The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 2000 342:1946 52.
28. Subbaramaiah K, Dannenberg AJ. Cyclooxygenase 2: a molecular target for cancer prevention and treatment. Trends Pharmacol Sci 2003 24:96 102.
29. Couzin J. Drug safety. Withdrawal of Vioxx casts a shadow over COX-2 inhibitors. Science 2004 306:384 5.
30. Baron JA, Cole BF, Sandler RS, Haile RW, Ahnen D, Bresalier R et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003 348:891 9.
31. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003 348:883 90.
32. Narisawa T, Sato M, Tani M, Kudo T, Takahashi T, Goto A. Inhibition of development of methylnitrosourea-induced rat colon tumours by indomethacin treatment. Cancer Res 1981 41:1954 7.
33. Fulton AM, Levy JG. Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin. Int J Cancer 1980 26:669 73.
34. Lynch NR, Salomon JC. Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. J Natl Cancer Inst 1979 62:117 21.
35. Tanaka T, Kojima T, Yoshimi N, Sugie S, Mori H. Inhibitory effect of the non-steroidal anti-inflammatory drug, indomethacin on the naturally occurring carcinogen, 1-hydroxyanthraquinone in male ACI/N rats. Carcinogenesis 1991 12:1949 52.
36. Panje WR. Regression of head and neck carcinoma with a prostaglandin-synthesis inhibitor. Arch Otolaryngol 1981 107:658 63.
37. Chulada PC, Thompson MB, Mahler JF, Doyle CM, Gaul BW, Lee C et al. Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res 2000 60:4705 8.
38. Williams CS, Tsujii M, Reese J, Dey SK, DuBois RN. Host cyclooxygenase-2 modulates carcinoma growth. J Clin Invest 2000 105:1589 94.
39. Pentland AP, Scott G, VanBuskirk J, Tanck C, LaRossa G, Brouxhon S. Cyclooxygenase-1 deletion enhances apoptosis but does not protect against ultraviolet light-induced tumors. Cancer Res 2004 64:5587 91.
40. Thurnher D, Bakroeva M, Schutz G, Pelzmann M, Formanek M, Knerer B et al. Non-steroidal anti-inflammatory drugs induce apoptosis in head and neck cancer cell lines. Acta Otolaryngol 2001 121:957 62.
41. Pelzmann M, Thurnher D, Gedlicka C, Martinek H, Knerer B. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells. J Oral Pathol Med 2004 33:607 13.